One way to thwart generics delays? Look skeptically at citizen petitions, FDA says

One tool drugmakers have used to delay generic versions of their blockbuster drugs is a seemingly humble, yet often effective one: the FDA citizen petition. But thanks to new agency guidance, that tool may not be so effective anymore.